stiripentol

08/01/2001 - "Stiripentol can be effective in severe myoclonic epilepsy in infancy. "
07/01/2015 - "Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan."
12/01/2023 - "To evaluate the safety and efficacy of stiripentol initiated before 2 years of age in patients with Dravet syndrome. "
01/01/2019 - "Efficacy of Stiripentol and the Clinical Outcome in Dravet Syndrome."
01/01/2018 - "Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations."

01/01/2018 - "Stiripentol is effective for generalized tonic-clonic and focal seizures. "
03/01/1993 - "Stiripentol in atypical absence seizures in children: an open trial."
04/01/2018 - "Stiripentol (STP) was administered when previously used AEDs had demonstrated cross-sensitivity and failed to control seizures. "
11/01/2012 - "Stiripentol was also statistically superior to placebo for secondary efficacy outcomes in the randomized controlled trial, which included the median number of seizures during the second month of the double-blind period and the mean percentage change from baseline in seizure frequency. "
06/01/2006 - "If seizures increased by at least 50% after randomization compared with baseline, the patients dropped out (primary end point): there were six patients on stiripentol and eight patients on placebo (not significant). "

05/01/2021 - "The aim of the present study was to evaluate the safety and efficacy of the add-on treatment of stiripentol (STP) in adult patients with severely pharmacoresistant focal or multifocal epilepsy. "
01/01/2022 - "We contacted the manufacturer of stiripentol and epilepsy experts to identify published, unpublished and ongoing trials. "
01/01/2020 - "We contacted Biocodex (the manufacturer of stiripentol) and epilepsy experts to identify published, unpublished and ongoing trials. "
10/01/2018 - "We contacted Biocodex (the manufacturer of stiripentol) and epilepsy experts to identify published, unpublished and ongoing trials. "
10/21/2015 - "We contacted Biocodex (the manufacturer of stiripentol) and epilepsy experts to identify published, unpublished and ongoing trials. "

09/01/2022 - "We previously reported our single-centre experience on the efficacy of adjunctive stiripentol treatment in a cohort of 132 patients with different types of refractory epilepsies. "
11/01/2019 - "Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study."
10/01/2018 - "Randomised, controlled, add-on trials of stiripentol in people with focal refractory epilepsy. "
10/21/2015 - "Randomised controlled add-on trials of stiripentol in patients with focal refractory epilepsy. "
01/31/2014 - "Randomised controlled add-on trials of stiripentol in patients with focal refractory epilepsy. "

01/01/2022 - "Randomised controlled trials of add-on stiripentol in people with drug-resistant focal epilepsy. "
01/01/2020 - "Randomised, controlled, add-on trials of stiripentol in people with drug-resistant focal epilepsy. "
06/01/2006 - "Stiripentol in childhood partial epilepsy: randomized placebo-controlled trial with enrichment and withdrawal design."
01/01/2022 - "We can draw no conclusions to support the use of stiripentol as add-on treatment for drug-resistant focal epilepsy. "
01/01/2022 - "To evaluate the efficacy and tolerability of stiripentol as add-on treatment for people with drug-resistant focal epilepsy who are taking AEDs. "